Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization.
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial.
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
HIV-1 Trans-Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission.
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.
Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice.